Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial

Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET

Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Joyce Allaire , Lifesci Advisors , Us Department Of Defense , Michael Curi Rutgers University , Drug Administration , Humacyte Inc , Nasdaq , Virtual Webinar , Include Key Opinion Leader Perspectives , Vascular Trauma , Michael Curi , Rutgers University , Regenerative Medicine Advanced Therapy , Top Line Data , Medicine Advanced Therapy , Investor Contact , Media Contact ,